A detailed history of Greylin Investment Mangement Inc transactions in Viatris Inc stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 675,599 shares of VTRS stock, worth $8.46 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
675,599
Previous 680,957 0.79%
Holding current value
$8.46 Million
Previous $8.13 Million 11.67%
% of portfolio
1.27%
Previous 1.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$10.05 - $12.02 $53,847 - $64,403
-5,358 Reduced 0.79%
675,599 $7.18 Million
Q1 2024

Apr 24, 2024

SELL
$11.27 - $13.53 $342,517 - $411,203
-30,392 Reduced 4.27%
680,957 $8.13 Million
Q4 2023

Jan 25, 2024

SELL
$8.77 - $10.85 $1.23 Million - $1.52 Million
-139,703 Reduced 16.42%
711,349 $7.7 Million
Q3 2023

Oct 10, 2023

BUY
$9.59 - $11.35 $255,314 - $302,171
26,623 Added 3.23%
851,052 $8.39 Million
Q2 2023

Jul 10, 2023

BUY
$9.02 - $10.29 $49,204 - $56,131
5,455 Added 0.67%
824,429 $8.23 Million
Q1 2023

Apr 07, 2023

BUY
$9.2 - $12.26 $54,877 - $73,130
5,965 Added 0.73%
818,974 $7.88 Million
Q4 2022

Jan 25, 2023

SELL
$8.72 - $11.56 $250,944 - $332,673
-28,778 Reduced 3.42%
813,009 $0
Q3 2022

Oct 13, 2022

BUY
$8.48 - $11.13 $2.72 Million - $3.57 Million
320,394 Added 61.45%
841,787 $7.17 Million
Q2 2022

Jul 11, 2022

BUY
$9.95 - $12.27 $2.4 Million - $2.95 Million
240,786 Added 85.81%
521,393 $5.46 Million
Q1 2022

May 20, 2022

BUY
$9.81 - $15.4 $1.52 Million - $2.39 Million
155,376 Added 124.07%
280,607 $3.05 Million
Q4 2021

Feb 15, 2022

BUY
$12.09 - $14.68 $1.51 Million - $1.84 Million
125,231 New
125,231 $1.69 Million
Q1 2021

May 12, 2021

SELL
$13.59 - $18.54 $209,218 - $285,423
-15,395 Closed
0 $0
Q4 2020

Jan 14, 2021

BUY
$14.3 - $18.74 $220,148 - $288,502
15,395 New
15,395 $289,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Greylin Investment Mangement Inc Portfolio

Follow Greylin Investment Mangement Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.